Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT04684056
Eligibility Criteria:
Inclusion Criteria:
* Patients with Non-valvular atrial fibrillation(NVAF) undergoing catheter ablation
* Direct oral anticoagulants (Rivaroxaban, Edoxaban or Dabigatran)are administered peri-operatively during catheter ablation.
Exclusion Criteria:
* Patients who have taken direct oral anticoagulants or warfarin before admission.
* Cross-replacement of oral anticoagulants, such as taking dabigatran before surgery and replacing Rivaroxaban after surgery.
* Abnormal coagulation tests (prothrombin time, partial thrombin time, thrombin time, antithrombin activity).
* Pregnant and lactating women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04684056
Study Brief:
Protocol Section:
NCT04684056